Detalhe da pesquisa
1.
Complete metabolic response with [18 F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer.
BJU Int
; 129(2): 174-181, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626220
2.
FDG-PET/CT for lymph node staging prior to radical cystectomy.
Eur J Hybrid Imaging
; 7(1): 13, 2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482566
3.
UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.
Scand J Urol
; 57(1-6): 2-9, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36540001
4.
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management.
Scand J Urol
; 58: 4-10, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096322
5.
Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study.
Eur Urol Open Sci
; 57: 37-44, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020529
6.
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review.
Cancers (Basel)
; 14(7)2022 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406463
7.
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Eur Urol
; 81(5): 523-532, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782206
8.
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy.
Eur Urol
; 81(1): e18-e19, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716048
9.
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
Urol Oncol
; 35(10): 606.e9-606.e16, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28676151
10.
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
Eur Urol
; 81(4): e92-e93, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039183